Skip to content

Adding telaprevir improves acute hepatitis C treatment for HIV-positive men

Daniel Fierer, Mt Sinai Medical Center, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Simeprevir & sofosbuvir demonstrates good early cure rate with or without ribavirin

Eric Lawitz, Alamo Medical Research, presenting at CROI 2013. © Liz Highleyman / hivandhepatitis.com

Malawi achieves seven-fold increase in ART for pregnant and breastfeeding women

Routine viral load monitoring almost halves risk of virologic failure in 18-month Kenyan study

Dr Frederick Sawe of the Kenya Medical Research Institute presenting at CROI 2013.

Faldaprevir ups interferon response in HIV/HCV co-infection

Douglas Dieterich, Mt Sinai School of Medicine, New York.  © Liz Highleyman / hivandhepatitis.com

Simeprevir pushes HCV cure rate above 75% for HIV/HCV co-infection

Douglas Dieterich, Mt Sinai School of Medicine, New York.  © Liz Highleyman / hivandhepatitis.com

Contraceptive injections and HIV infection risk – a public health conundrum

Dr Chelsea Polis of USAID presenting at CROI 2013.

New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy

Second-line NRTI-sparing regimen proves equally effective for resource-limited settings